DALVX
Price
$20.70
Change
+$0.14 (+0.68%)
Updated
Jul 3 closing price
Net Assets
174.94M
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

DALVX vs VIVAX

Header iconDALVX vs VIVAX Comparison
Open Charts DALVX vs VIVAXBanner chart's image
Dunham Large Cap Value A
Price$20.70
Change+$0.14 (+0.68%)
VolumeN/A
Net Assets174.94M
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
DALVX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DALVX vs. VIVAX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DALVX is a StrongBuy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. DALVX (175M). VIVAX pays higher dividends than DALVX: VIVAX (2.06) vs DALVX (0.53). DALVX was incepted earlier than VIVAX: DALVX (19 years) vs VIVAX (33 years). DALVX (1.44) is less costly to investors than VIVAX (0.17). DALVX is a more actively managed with annual turnover of: 23.00 vs. VIVAX (9.00). VIVAX has a lower initial minimum investment than DALVX: VIVAX (3000) vs DALVX (5000). VIVAX annual gain was more profitable for investors over the last year : 12.04 vs. DALVX (10.24). VIVAX return over 5 years is better than : 80.14 vs. DALVX (65.92).
DALVXVIVAXDALVX / VIVAX
Total Expense Ratio1.440.17847%
Annual Report Gross Expense Ratio1.440.17847%
Fund Existence19 years33 years-
Gain YTD8.2646.209133%
Front Load6%N/A-
Min. Initial Investment50003000167%
Min. Initial Investment IRAN/AN/A-
Net Assets175M189B0%
Annual Yield % from dividends0.532.0626%
Returns for 1 year10.2412.0485%
Returns for 3 years30.0935.1686%
Returns for 5 years65.9280.1482%
Returns for 10 years35.62115.7431%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOL1.910.03
+1.60%
Emeren Group Ltd
CE60.880.26
+0.43%
Celanese Corp
BNL16.340.03
+0.18%
Broadstone Net Lease
BCLI1.16-0.01
-0.85%
Brainstorm Cell Therapeutics
ECX2.16-0.04
-1.82%
ECARX Holdings